Patient Care

Avio Health Launches World’s First Functional Medicine LLM for Emagene Life, Transforming Personalized Healthcare

KUALA LUMPUR, Malaysia, June 27, 2025 /PRNewswire/ -- Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced the launch of the world's...

Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays

Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen – as second-tier testHOUSTON, June...

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen...

Veterinary Practice Management Software Market to Reach $898.9 Million by 2035, Growing at 7.8% CAGR–Exclusive Report by Meticulous Research®

Market Growth Driven by Rising Pet Ownership, Digital Transformation in Veterinary Care, Cloud-Based Solutions, and Growing Animal Health Expenditure REDDING,...

96% of health care executives are “ready and resourced” to use digital health solutions, yet two-thirds say interoperability is “a tough but manageable challenge,” reveals new MIT Technology Review Insights report

Century Health Partners with Nimbus Health to Accelerate Respiratory Disease Research Through AI-Powered Clinical Registries

Real-world evidence is increasingly critical to understanding patient outcomes from pulmonary care and pharmaceutical treatmentsThis partnership with Nimbus Health will...

Nephrolytics Closes $2.5M SAFE Round, Launches Saya™ First Full Stack Agentic Solution for Kidney Disease Care, and Showcases Breakthrough at RPA 2025

CHUBBUCK, Idaho, June 25, 2025 /PRNewswire/ -- Nephrolytics, Inc., the AI-powered clinical intelligence platform revolutionizing kidney care, today announced three...

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of...

The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System

error: Content is protected !!